Alkylating Drug class drugs
16 results
Bendeka (bendamustine hydrochloride)
(bendamustine hydrochloride)Teva Pharmaceuticals USA, Inc.
Usage: BENDEKA® is indicated for treating chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of rituximab treatment. Efficacy compared to certain first-line therapies in CLL has not been established.
Gliadel (carmustine)
(carmustine)Arbor Pharmaceuticals
Usage: GLIADEL Wafer is indicated for treating newly-diagnosed high-grade glioma as an adjunct to surgery and radiation, and for recurrent glioblastoma as an adjunct to surgery.
Jelmyto (mitomycin)
(mitomycin)UroGen Pharma, Inc.
Usage: JELMYTO® is indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC).
Melphalan hydrochloride (melphalan hydrochloride)
(Melphalan hydrochloride)Meitheal Pharmaceuticals Inc.
Usage: Melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma who are unable to receive oral therapy.
Melphalan hydrochloride (melphalan hydrochloride)
(MELPHALAN HYDROCHLORIDE)Xiromed, LLC
Usage: Melphalan Hydrochloride for Injection is indicated for the palliative treatment of patients with multiple myeloma when oral therapy is not suitable.
Melphalan hydrochloride (melphalan hydrochloride)
(MELPHALAN HYDROCHLORIDE)Camber Pharmaceuticals, Inc.
Usage: Melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma when oral therapy is unsuitable.
Mitosol (mitomycin)
(mitomycin)Mobius Therapeutics LLC
Usage: Mitosol® is indicated as an adjunct treatment during ab externo glaucoma surgery to help manage intraocular pressure by inhibiting fibroblast proliferation.
Myleran (busulfan)
(busulfan)Waylis Therapeutics LLC
Usage: MYLERAN (busulfan) is indicated for the palliative treatment of chronic myelogenous leukemia.
Temozolomide (temozolomide)
(TEMOZOLOMIDE)Camber Pharmaceuticals, Inc.
Usage: Temozolomide capsules are indicated for treating adults with newly diagnosed glioblastoma (alongside radiotherapy and as maintenance) and for both adjuvant and refractory treatment of newly diagnosed anaplastic astrocytoma.
Temozolomide (temozolomide)
(Temozolomide)Lannett Company, Inc.
Usage: Temozolomide is indicated for adult patients with newly diagnosed glioblastoma multiforme, used alongside radiotherapy and as maintenance treatment. It is also indicated for those with refractory anaplastic astrocytoma who have disease progression following treatment with nitrosourea and procarbazine.